ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1585

Presence of Swollen and Tender Joints in Patients Fulfilling Minimal Disease Activity Criteria

Josefina Marin1, Maria L. Acosta Felquer2, Leandro Ferreyra-Garrot1, Santiago Ruta3, Javier Rosa1 and Enrique R. Soriano4, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Internal Medicine, Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 3Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Activity score and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment II

Session Type: Abstract Submissions (ACR)

Background/Purpose

Minimal disease activity (MDA) is a composite measure created for patients with psoriatic arthritis (PsA) that encompasses many clinically important aspects of PsA: arthritis, psoriasis, enthesitis, pain, patient-assessed global disease activity, and physical function. A patient is considered to be in MDA if fulfills 5/7 criteria. In theory, a patient could be in MDA, but still have several tender and/or swollen joints.Objectives:1) To evaluate the number of patients fulfilling MDA criteria that still have several tender/swollen joints, and 2) To analyze the components of MDA that contribute most to prevent patients achieving MDA.

Methods

Consecutive patients with PsA (CASPAR criteria) were included, and all components of MDA score were assessed by a single experienced Rheumatologist. Patients were classified as in MDA if they fulfilled 5/7 criteria (tender joint count (TJC; 0–68) ≤ 1; swollen joint count (SJC; 0–66) ≤ 1; PASI ≤ 1 or BSA ≤ 3%; patient pain score on a visual analog scale (VAS; 0–100) ≤ 15; patient global assessment of disease activity (PaGA; VAS; 0–100) ≤ 20 mm; Health Assessment Questionnaire (HAQ; 0–3) ≤ 0.5; and tender entheseal points (0–13) ≤ 1). Percentage of patients with >= 2 tender and/or swollen joints within patients in MDA was calculated. We also calculated the percentage of patients not fulfilling each one of the criteria for those patients with 4 out of 7 MDA criteria.

Results

83 patients were included. Patient’s characteristics according to MDA status are shown in the table. Among the 41 patients fulfilling MDA criteria, only one patient (2.4 %) showed more than 2 tender joints (3 tender joints), and two other patients showed >=2 swollen joints (one patient two and one patient three swollen joints). Altogether 7.4 % of patients, fulfilling MDA criteria presented a clinically significant number of tender/swollen joints.Among patients fulfilling MDA criteria, only 24 % fulfilled all 7 criteria, and 32 % and 43% fulfilled 6 and 5 criteria respectively. Of those patients not in MDA status, 17 (40.5 %) fulfilled 4/7 criteria. Among those patients, the criteria more often not fulfilled were: patient pain score VAS ≤ 15= 100 %; PaGA VAS ≤ 20 mm =76.5 %; and PASI ≤ 1 = 65 %. Only 29 %, 18 %, 6% and 6 % did not fulfilled tender joint count, HAQ, swollen joint count and entheseal tenderness criteria, respectively

Characteristics

MDA (n=41)

No MDA (n=42)

P value

Male sex (%)

23 (56)

21 (50)

0.578

Mean age yrs (SD)

55.6 (13.6)

51.2(14.3)

0.1528

Median months disease duration (IQR)

36 (12-96)

31.5 (10-48)

0.3460

Mean pain VAS mm (SD)

17.5 (20.1)

52.7 (20.1)

<0.0001

Mean Patient Global Activity VAS mm (SD)

14 (18.2)

47.2 (21.2)

<0.0001

Mean swollen joint count (SD)

0.3 (0.6)

2.7 (2.6)

<0.0001

Mean tender joint count (SD)

0.3 (0.6)

1.8 (2.6)

0.0003

Mean HAQ (SD)

0.15 (0.37)

0.43 (0.51)

0.0047

Mean tender entheseal points (SD)

0.12 (0.33)

0.49 (0.87)

0.0121

Mean PASI (SD)

1.5 (2.2)

3.8 (4.8)

0.0074

Mean DAS28 (SD)

2.3 (0.71)

3.7 (1.1)

<0.0001

Mean CPDAI (SD)

2.1 (1)

4 (1.9)

<0.0001

Mean ESR (SD)

19.8 (14.2)

24.8 (19.5)

0.1737

Number with >=2 tender joint count (%)

1 (2.4)

27 (64.3)

<0.0001

Number with >=2 swollen joint count (%)

2 (4.9)

18 (43)

0.002

Conclusion

Although possible in theory, only a minority of patients fulfilling MDA criteria present a clinically significant number of tender and/or swollen joints. In patients that were close to fulfill MDA criteria patient’s VAS scores (pain and disease activity) and PASI were the most frequent reasons to fall short to MDA status.


Disclosure:

J. Marin,
None;

M. L. Acosta Felquer,
None;

L. Ferreyra-Garrot,
None;

S. Ruta,
None;

J. Rosa,
None;

E. R. Soriano,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-swollen-and-tender-joints-in-patients-fulfilling-minimal-disease-activity-criteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology